aluates Reports

$ 0.0

Automative

Global Pharmacovigilance (PV) Outsourcing Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-25H5903

Global Pharmacovigilance PV Outsourcing Market Insights Forecast to 2028

BUY CHAPTERS

Global Pharmacovigilance (PV) Outsourcing Market Research Report 2024

Code: QYRE-Auto-25H5903

Report

February 2024

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Pharmacovigilance (PV) Outsourcing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacovigilance (PV) Outsourcing Market

The global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance (PV) Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance (PV) Outsourcing.

Report Scope

The Pharmacovigilance (PV) Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance (PV) Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacovigilance (PV) Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmacovigilance (PV) Outsourcing Market Report

Report Metric	Details
Report Name	Pharmacovigilance (PV) Outsourcing Market
CAGR	5%
Segment by Type	Contract Research Organizations (CROs) Business Process Outsourcing (BPOs)
Segment by Application	Premarketing Clinical Trial Post-marketing Clinical Practice Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation, iMED Global Corporation, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PharmInvent, PrimeVigilance, Pure Drug Safety, Sciformix, SIRO Clinpharm, Symogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacovigilance (PV) Outsourcing Market report?

Ans: The main players in the Pharmacovigilance (PV) Outsourcing Market are Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation, iMED Global Corporation, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PharmInvent, PrimeVigilance, Pure Drug Safety, Sciformix, SIRO Clinpharm, Symogen

What are the Application segmentation covered in the Pharmacovigilance (PV) Outsourcing Market report?

Ans: The Applications covered in the Pharmacovigilance (PV) Outsourcing Market report are Premarketing Clinical Trial, Post-marketing Clinical Practice, Other

What are the Type segmentation covered in the Pharmacovigilance (PV) Outsourcing Market report?

Ans: The Types covered in the Pharmacovigilance (PV) Outsourcing Market report are Contract Research Organizations (CROs), Business Process Outsourcing (BPOs)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Contract Research Organizations (CROs)

1.2.3 Business Process Outsourcing (BPOs)

1.3 Market by Application

1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Premarketing Clinical Trial

1.3.3 Post-marketing Clinical Practice

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2019-2030)

2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Region

2.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2019-2024)

2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2025-2030)

2.3 Pharmacovigilance (PV) Outsourcing Market Dynamics

2.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends

2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers

2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges

2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue

3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2019-2024)

3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2019-2024)

3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue

3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio

3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2023

3.5 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served

3.6 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service

3.7 Date of Enter into Pharmacovigilance (PV) Outsourcing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type

4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2019-2024)

4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2025-2030)

5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application

5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2019-2024)

5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)

6.2 North America Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)

6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)

7.2 Europe Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)

7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)

8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024)

8.4 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)

9.2 Latin America Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)

9.4 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)

10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)

10.4 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Accenture

11.1.1 Accenture Company Detail

11.1.2 Accenture Business Overview

11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction

11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.1.5 Accenture Recent Development

11.2 C3i Solutions

11.2.1 C3i Solutions Company Detail

11.2.2 C3i Solutions Business Overview

11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction

11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.2.5 C3i Solutions Recent Development

11.3 Clintec

11.3.1 Clintec Company Detail

11.3.2 Clintec Business Overview

11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction

11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.3.5 Clintec Recent Development

11.4 Covance

11.4.1 Covance Company Detail

11.4.2 Covance Business Overview

11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction

11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.4.5 Covance Recent Development

11.5 Deloitte Touche Tohmatsu Limited

11.5.1 Deloitte Touche Tohmatsu Limited Company Detail

11.5.2 Deloitte Touche Tohmatsu Limited Business Overview

11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction

11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.5.5 Deloitte Touche Tohmatsu Limited Recent Development

11.6 ELC Group

11.6.1 ELC Group Company Detail

11.6.2 ELC Group Business Overview

11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction

11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.6.5 ELC Group Recent Development

11.7 Ergomed

11.7.1 Ergomed Company Detail

11.7.2 Ergomed Business Overview

11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction

11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.7.5 Ergomed Recent Development

11.8 iGATE Corporation

11.8.1 iGATE Corporation Company Detail

11.8.2 iGATE Corporation Business Overview

11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction

11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.8.5 iGATE Corporation Recent Development

11.9 iMED Global Corporation

11.9.1 iMED Global Corporation Company Detail

11.9.2 iMED Global Corporation Business Overview

11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction

11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.9.5 iMED Global Corporation Recent Development

11.10 IQVIA

11.10.1 IQVIA Company Detail

11.10.2 IQVIA Business Overview

11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction

11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.10.5 IQVIA Recent Development

11.11 MarksMan Healthcare

11.11.1 MarksMan Healthcare Company Detail

11.11.2 MarksMan Healthcare Business Overview

11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction

11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.11.5 MarksMan Healthcare Recent Development

11.12 Medpace Holdings

11.12.1 Medpace Holdings Company Detail

11.12.2 Medpace Holdings Business Overview

11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction

11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.12.5 Medpace Holdings Recent Development

11.13 Novartis

11.13.1 Novartis Company Detail

11.13.2 Novartis Business Overview

11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction

11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.13.5 Novartis Recent Development

11.14 Oracle Corporation

11.14.1 Oracle Corporation Company Detail

11.14.2 Oracle Corporation Business Overview

11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction

11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.14.5 Oracle Corporation Recent Development

11.15 Parexel

11.15.1 Parexel Company Detail

11.15.2 Parexel Business Overview

11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction

11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.15.5 Parexel Recent Development

11.16 PharmInvent

11.16.1 PharmInvent Company Detail

11.16.2 PharmInvent Business Overview

11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction

11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.16.5 PharmInvent Recent Development

11.17 PrimeVigilance

11.17.1 PrimeVigilance Company Detail

11.17.2 PrimeVigilance Business Overview

11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction

11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.17.5 PrimeVigilance Recent Development

11.18 Pure Drug Safety

11.18.1 Pure Drug Safety Company Detail

11.18.2 Pure Drug Safety Business Overview

11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction

11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.18.5 Pure Drug Safety Recent Development

11.19 Sciformix

11.19.1 Sciformix Company Detail

11.19.2 Sciformix Business Overview

11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction

11.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.19.5 Sciformix Recent Development

11.20 SIRO Clinpharm

11.20.1 SIRO Clinpharm Company Detail

11.20.2 SIRO Clinpharm Business Overview

11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction

11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.20.5 SIRO Clinpharm Recent Development

11.21 Symogen

11.21.1 Symogen Company Detail

11.21.2 Symogen Business Overview

11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction

11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

11.21.5 Symogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Contract Research Organizations (CROs)

Table 3. Key Players of Business Process Outsourcing (BPOs)

Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2019-2024)

Table 8. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2025-2030)

Table 10. Pharmacovigilance (PV) Outsourcing Market Trends

Table 11. Pharmacovigilance (PV) Outsourcing Market Drivers

Table 12. Pharmacovigilance (PV) Outsourcing Market Challenges

Table 13. Pharmacovigilance (PV) Outsourcing Market Restraints

Table 14. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Pharmacovigilance (PV) Outsourcing Market Share by Players (2019-2024)

Table 16. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2023)

Table 17. Ranking of Global Top Pharmacovigilance (PV) Outsourcing Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service

Table 21. Date of Enter into Pharmacovigilance (PV) Outsourcing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2019-2024)

Table 25. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2025-2030)

Table 27. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2019-2024)

Table 29. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2025-2030)

Table 31. North America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Accenture Company Detail

Table 47. Accenture Business Overview

Table 48. Accenture Pharmacovigilance (PV) Outsourcing Product

Table 49. Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 50. Accenture Recent Development

Table 51. C3i Solutions Company Detail

Table 52. C3i Solutions Business Overview

Table 53. C3i Solutions Pharmacovigilance (PV) Outsourcing Product

Table 54. C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 55. C3i Solutions Recent Development

Table 56. Clintec Company Detail

Table 57. Clintec Business Overview

Table 58. Clintec Pharmacovigilance (PV) Outsourcing Product

Table 59. Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 60. Clintec Recent Development

Table 61. Covance Company Detail

Table 62. Covance Business Overview

Table 63. Covance Pharmacovigilance (PV) Outsourcing Product

Table 64. Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 65. Covance Recent Development

Table 66. Deloitte Touche Tohmatsu Limited Company Detail

Table 67. Deloitte Touche Tohmatsu Limited Business Overview

Table 68. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product

Table 69. Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 70. Deloitte Touche Tohmatsu Limited Recent Development

Table 71. ELC Group Company Detail

Table 72. ELC Group Business Overview

Table 73. ELC Group Pharmacovigilance (PV) Outsourcing Product

Table 74. ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 75. ELC Group Recent Development

Table 76. Ergomed Company Detail

Table 77. Ergomed Business Overview

Table 78. Ergomed Pharmacovigilance (PV) Outsourcing Product

Table 79. Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 80. Ergomed Recent Development

Table 81. iGATE Corporation Company Detail

Table 82. iGATE Corporation Business Overview

Table 83. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product

Table 84. iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 85. iGATE Corporation Recent Development

Table 86. iMED Global Corporation Company Detail

Table 87. iMED Global Corporation Business Overview

Table 88. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product

Table 89. iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 90. iMED Global Corporation Recent Development

Table 91. IQVIA Company Detail

Table 92. IQVIA Business Overview

Table 93. IQVIA Pharmacovigilance (PV) Outsourcing Product

Table 94. IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 95. IQVIA Recent Development

Table 96. MarksMan Healthcare Company Detail

Table 97. MarksMan Healthcare Business Overview

Table 98. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product

Table 99. MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 100. MarksMan Healthcare Recent Development

Table 101. Medpace Holdings Company Detail

Table 102. Medpace Holdings Business Overview

Table 103. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product

Table 104. Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 105. Medpace Holdings Recent Development

Table 106. Novartis Company Detail

Table 107. Novartis Business Overview

Table 108. Novartis Pharmacovigilance (PV) Outsourcing Product

Table 109. Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 110. Novartis Recent Development

Table 111. Oracle Corporation Company Detail

Table 112. Oracle Corporation Business Overview

Table 113. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product

Table 114. Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 115. Oracle Corporation Recent Development

Table 116. Parexel Company Detail

Table 117. Parexel Business Overview

Table 118. Parexel Pharmacovigilance (PV) Outsourcing Product

Table 119. Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 120. Parexel Recent Development

Table 121. PharmInvent Company Detail

Table 122. PharmInvent Business Overview

Table 123. PharmInvent Pharmacovigilance (PV) Outsourcing Product

Table 124. PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 125. PharmInvent Recent Development

Table 126. PrimeVigilance Company Detail

Table 127. PrimeVigilance Business Overview

Table 128. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product

Table 129. PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 130. PrimeVigilance Recent Development

Table 131. Pure Drug Safety Company Detail

Table 132. Pure Drug Safety Business Overview

Table 133. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product

Table 134. Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 135. Pure Drug Safety Recent Development

Table 136. Sciformix Company Detail

Table 137. Sciformix Business Overview

Table 138. Sciformix Pharmacovigilance (PV) Outsourcing Product

Table 139. Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 140. Sciformix Recent Development

Table 141. SIRO Clinpharm Company Detail

Table 142. SIRO Clinpharm Business Overview

Table 143. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product

Table 144. SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 145. SIRO Clinpharm Recent Development

Table 146. Symogen Company Detail

Table 147. Symogen Business Overview

Table 148. Symogen Pharmacovigilance (PV) Outsourcing Product

Table 149. Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)

Table 150. Symogen Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2023 VS 2030

Figure 3. Contract Research Organizations (CROs) Features

Figure 4. Business Process Outsourcing (BPOs) Features

Figure 5. Global Pharmacovigilance (PV) Outsourcing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2023 VS 2030

Figure 7. Premarketing Clinical Trial Case Studies

Figure 8. Post-marketing Clinical Practice Case Studies

Figure 9. Other Case Studies

Figure 10. Pharmacovigilance (PV) Outsourcing Report Years Considered

Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2023 VS 2030

Figure 14. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2023

Figure 15. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2023

Figure 17. North America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)

Figure 19. United States Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)

Figure 23. Germany Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Region (2019-2030)

Figure 31. China Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)

Figure 39. Mexico Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)

Figure 43. Turkey Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 46. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 47. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 48. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 49. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 50. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 51. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 52. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 53. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 54. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 55. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 56. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 57. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 58. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 59. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 60. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 61. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 62. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 63. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 64. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 65. Symogen Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmacovigilance (PV) Outsourcing Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-25H5903

Global Pharmacovigilance (PV) Outsourcing Market Research Report 2024

FEATURED COMPANIES

Pharmacovigilance (PV) Outsourcing Market Size

Pharmacovigilance (PV) Outsourcing Market

Report Scope

Scope of Pharmacovigilance (PV) Outsourcing Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Pharmacovigilance (PV) Outsourcing Market report?

What are the Application segmentation covered in the Pharmacovigilance (PV) Outsourcing Market report?

What are the Type segmentation covered in the Pharmacovigilance (PV) Outsourcing Market report?

FEATURED COMPANIES